Does EPIRUBICIN Cause Neoplasm recurrence? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Neoplasm recurrence have been filed in association with EPIRUBICIN (Ellence). This represents 0.1% of all adverse event reports for EPIRUBICIN.
15
Reports of Neoplasm recurrence with EPIRUBICIN
0.1%
of all EPIRUBICIN reports
5
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm recurrence From EPIRUBICIN?
Of the 15 reports, 5 (33.3%) resulted in death, 1 (6.7%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPIRUBICIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does EPIRUBICIN Cause?
Nausea (1,265)
Vomiting (978)
Myelosuppression (934)
Neutropenia (926)
White blood cell count decreased (873)
Febrile neutropenia (809)
Diarrhoea (749)
Asthenia (732)
Pyrexia (729)
Fatigue (685)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which EPIRUBICIN Alternatives Have Lower Neoplasm recurrence Risk?
EPIRUBICIN vs EPLERENONE
EPIRUBICIN vs EPLONTERSEN
EPIRUBICIN vs EPOETIN ALFA-EPBX
EPIRUBICIN vs EPOGEN
EPIRUBICIN vs EPOPROSTENOL